
ASN Kidney Translation Series: JASN Late-Breaking Clinical Trials
Shownotes
This episode of ASN Kidney Translation Podcast, we review 2 late-breaking clinical trials: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. The authors discuss efficacy, safety, and implications for kidney practice
Alle Folgen von Journal of the American Society of Nephrology (JASN)